Table 3 Characteristics of patients selected after propensity score matching
|  | C-ion RT (n = 17) | TACE (n = 17) | p-value |
|---|---|---|---|
Age, year, median (range) | 75 (45–85) | 78 (59–90) | 0.93 |
Sex ratio (male: female) | 8:9 | 9:8 | 0.74 |
AFP, ng/ml, median (range) | 8.8 (1.6–386.2) | 8.0 (2.0–175.6) | 1.00 |
PS (0:1:2) | 8:7:2 | 8:9:0 | 0.72 |
Child-Pugh class (A:B:C) | 15:2:0 | 14:3:0 | 0.47 |
BCLC classification (A:B:C) | 8:0:9 | 9:0:8 | 0.74 |
Tumor size, mm, median (range) | 30 (11–64) | 30 (8–60) | 0.98 |
Etiology, (HCV-Ag:HBs-Ab:NASH/NAFLD:Alcohol) | 11:2:4:0 | 10:1:4:2 | Â |
Total dose of C-ion RT, (52.8 Gy (RBE)/4 fr: 60 Gy (RBE)/4 fr: 60 Gy (RBE)/12 fr) | 7:10:0 |  |  |